Education
About Us
Working with TipRanks
Follow Us
Insight Molecular Diagnostics (IMDX)
NASDAQ:IMDX
Earnings Data
Report Date
Apr 01, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.24Last Year’s EPS
-0.26Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call reflected a generally positive outlook with significant advancements in product development and financial stability. However, the uncertainty due to the government shutdown and slower-than-expected clinical trial enrollment presents challenges.Company Guidance
Product Development and FDA Submission Progress
Insight Molecular Diagnostics is nearing FDA submission for GraftAssure DX, with plans to submit by the end of 2025. They have made significant progress in clinical trials and product development, including optimization of assay workflow and strong performance results from international studies.
Financial Stability and Cash Management
The company ended the quarter with $20 million in cash and no debt. They maintained a cash burn below their target, demonstrating effective cash management.
Clinical Trial and Registry Program Advancements
Successful implementation of a registry program to gather real-world data and clinician feedback, which is expected to aid in product adoption and market education.
IMDX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
IMDX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 10, 2025 | $6.80 | $7.52 | +10.59% |
Aug 11, 2025 | $2.61 | $2.51 | -3.83% |
May 12, 2025 | $2.81 | $2.77 | -1.42% |
Mar 24, 2025 | $3.33 | $3.04 | -8.71% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Insight Molecular Diagnostics (IMDX) report earnings?
Insight Molecular Diagnostics (IMDX) is schdueled to report earning on Apr 01, 2026, After Close (Confirmed).
What is Insight Molecular Diagnostics (IMDX) earnings time?
Insight Molecular Diagnostics (IMDX) earnings time is at Apr 01, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is IMDX EPS forecast?
IMDX EPS forecast for the fiscal quarter 2025 (Q4) is -0.24.